← Leaderboards
Alexandra M Levine
University Of Southern California
$34,706,653
Attributed
$34,706,653
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.8M · FY2005–08$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
Funding mix
By agency
NIH$34,706,653 · 13
By mechanism
U01$32,037,135 · 3
M01$2,086,839 · 8
K12$582,679 · 1
P30$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Howard N Hodis$51,156,356
- Derek Raghavan$1,863,220
- Caleb E Finch$20,916,232
- James Raschko$191,317
- Ronald K Ross$16,986,381
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationAids TherapyKaposi'S SarcomaAids Related Neoplasm /CancerLymphomaHiv InfectionsAidsCooperative StudyTissue Resource /RegistryNonhodgkin'S LymphomaNeoplasm /Cancer ChemotherapyCombination ChemotherapyCyclophosphamideMedical Outreach /Case FindingVirus LoadHuman Immunodeficiency VirusIndinavirHuman Immunodeficiency Virus 1LamivudineFemaleExperimental DesignsFunding
Grant awards (39)
Southern California Women's Interagency HIV Study Consortium$2,910,886
U01 · FY2008 · HD · contact PI
A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY$44,463
M01 · FY2008 · RR · contact PI
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)$39,251
M01 · FY2008 · RR · contact PI
Women's Interagency HIV Study$3,993,927
U01 · FY2007 · HD · contact PI
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)$244,131
M01 · FY2007 · RR · contact PI
A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY$35,856
M01 · FY2007 · RR · contact PI
Women's Interagency HIV Study$3,573,866
U01 · FY2006 · HD · contact PI
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)$1,111,463
M01 · FY2006 · RR · contact PI
University of Southern California$149,960
U01 · FY2006 · CA · contact PI
Women's Interagency HIV Study$3,450,189
U01 · FY2005 · HD
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)$238,795
M01 · FY2005 · RR
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$149,157
U01 · FY2005 · CA
Women's Interagency HIV Study$3,587,840
U01 · FY2004 · HD
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$130,885
U01 · FY2004 · CA
A RANDOMIZED PHASE II TRIAL OF EPOCH$25,799
M01 · FY2004 · RR
Women's Interagency HIV Study$3,617,717
U01 · FY2003 · HD
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$265,404
U01 · FY2003 · CA
WOMENS INTERAGENCY HIV STUDY (WIHS)$3,568,374
U01 · FY2002 · HD
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$260,637
U01 · FY2002 · CA
PILOT--HEMATOLOGIC MALIGNANCY/RETROVIRAL DISEASE$0
P30 · FY2002 · CA
AMC 005--CHOP &TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS$0
M01 · FY2002 · RR
PILOT--HEMATOLOGIC MALIGNANCY/RETROVIRAL DISEASE$0
P30 · FY2002 · CA
WOMEN'S INTERAGENCY HIV STUDY (WIHS)$2,797,531
U01 · FY2001 · HD
WOMEN'S INTERAGENCY HIV STUDY (WIHS)$286,991
U01 · FY2001 · HD
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$254,849
U01 · FY2001 · CA
AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM$246,606
K12 · FY2001 · CA
AMC 005--CHOP &TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS$155,764
M01 · FY2001 · RR
PILOT--HEMATOLOGIC MALIGNANCY/RETROVIRAL DISEASE$0
P30 · FY2001 · CA
PILOT--HEMATOLOGIC MALIGNANCY/RETROVIRAL DISEASE$0
P30 · FY2001 · CA
AMC 005--CHOP &TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS$0
M01 · FY2001 · RR
WOMEN'S INTERAGENCY HIV STUDY (WIHS)$2,788,288
U01 · FY2000 · HD
AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM$336,073
K12 · FY2000 · CA
AIDS ASSOCIATED MALIGNANCIES CLINICAL TRIALS CONSORTIUM$250,634
U01 · FY2000 · CA
AMC 005--CHOP &TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS$155,764
M01 · FY2000 · RR
AMC 005--CHOP &TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS$35,553
M01 · FY2000 · RR
AMC010: CHOP CHEMOTHERAPY &RETUXIMAB FOR HIV NONHODGKIN'S LYMPHOMA$0
M01 · FY2000 · RR
AMC010: CHOP CHEMOTHERAPY &RETUXIMAB FOR HIV NONHODGKIN'S LYMPHOMA$0
M01 · FY2000 · RR
AMC008: IL2 FOLLOWING IFOSFAMIDE/ETOPOSIDE FOR HIV NONHODGKIN'S LYMPHOMA$0
M01 · FY2000 · RR
AMC008: IL2 FOLLOWING IFOSFAMIDE/ETOPOSIDE FOR HIV NONHODGKIN'S LYMPHOMA$0
M01 · FY2000 · RR